News

Esteemed Respiratory Healthcare Expert, Carol Stonham, Joins the Medical Advisory Board for Medtech Company, Bedfont Scientific Ltd. Bedfont® Scientific Ltd, a leading innovator in breath analysis medical device technology, is proud to announce the addition of Carol Stonham, a highly...

Harnessing the Power of FeNO Monitoring to Combat Lung Conditions – A Vital Step in Addressing the UK's Lung Health Crisis A new report from PwC commissioned by Asthma+Lung UK has highlighted the alarming crisis surrounding Lung Health in the...

Access to prevention and treatment for all. Leave no one behind: Organised by the Forum of International Respiratory Societies (FIRS) since 2016, World Lung Day is a time for everyone to take a look at what we can do individually...

The National FeNO Programme has recently released its Impact Report, promoting how their programme has improved access to fractional exhaled nitric oxide (FeNO) testing across the National Health Service (NHS) in England. The programme ran from April 2021 to March...

Bedfont® opens a new wellness space for encouraging a carbon conscious approach and memorialising loved ones Bedfont® proudly announces the successful transformation of unused space into a Wellbeing Garden. This innovative initiative not only underlines Bedfont's commitment to its employees'...

Bedfont® Scientific Ltd. helps fundraising reach £1000 for Cancer Research UK Local Med-tech company, Bedfont® Scientific Ltd., is proudly donating £200 to support the noble fundraising efforts of its employees, the Bedfont® Family, who ran the Pretty Muddy 5K Obstacle...